Mediators of Inflammation

Mediators of Inflammation / 2007 / Article

Research Article | Open Access

Volume 2007 |Article ID 026785 | https://doi.org/10.1155/2007/26785

Velio Bocci, Carlo Aldinucci, Francesca Mosci, Fabio Carraro, Giuseppe Valacchi, "Ozonation of Human Blood Induces a Remarkable Upregulation of Heme Oxygenase-1 and Heat Stress Protein-70", Mediators of Inflammation, vol. 2007, Article ID 026785, 6 pages, 2007. https://doi.org/10.1155/2007/26785

Ozonation of Human Blood Induces a Remarkable Upregulation of Heme Oxygenase-1 and Heat Stress Protein-70

Received07 Jun 2007
Accepted23 Aug 2007
Published20 Sep 2007

Abstract

Heme oxygenase-I (HO-1) has emerged as one of the most protective enzymes and its pleiotropic activities have been demonstrated in a variety of human pathologies. Unpublished observations have shown that HO-1 is induced after the infusion of ozonated blood into the respective donors, and many other experimental observations have demonstrated the efficacy of oxidizing agents. It appeared worthwhile to evaluate whether we could better define the activity of potential inducers such as hydrogen peroxide and ozonated human plasma. Human vascular endothelial cells at confluence were challenged with different concentrations of these inducers and the simultaneous production of nitric oxide (NO); and HO-1 was measured by either measuring nitrite, or bilirubin formation, or/and the immune reactivity of the protein by Western blot using a rabbit antihuman HO-1 and Hsp-70. The results show that production of both NO and HO-1 is fairly dose dependent but is particularly elevated using human plasma after transient exposure to a medium ozone concentration. At this concentration, there is also induction of Hsp-70. The results clarify another positive effect achievable by the use of ozone therapy.

References

  1. B. S. Zuckerbraun and T. R. Billiar, “Heme oxygenase-1: a cellular hercules,” Hepatology, vol. 37, no. 4, pp. 742–744, 2003. View at: Publisher Site | Google Scholar
  2. R. Tenhunen, H. Marver, N. R. Pimstone, W. F. Trager, D. Y. Cooper, and R. Schmid, “Enzymatic degradation of heme: oxygenative cleavage requiring cytochrome P-450,” Biochemistry, vol. 11, no. 9, pp. 1716–1720, 1972. View at: Publisher Site | Google Scholar
  3. G. Balla, H. S. Jacob, and J. Balla et al., “Ferritin: a cytoprotective antioxidant stratagem of endothelium,” Journal of Biological Chemistry, vol. 267, pp. 18148–18153, 1992. View at: Google Scholar
  4. D. E. Barañano, M. Rao, C. D. Ferris, and S. H. Snyder, “Biliverdin reductase: a major physiologic cytoprotectant,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 25, pp. 16093–16098, 2002. View at: Publisher Site | Google Scholar
  5. A. Verma, D. J. Hirsch, C. E. Glatt, G. V. Ronnett, and S. H. Snyder, “Carbon monoxide: a putative neural messenger,” Science, vol. 259, no. 5093, pp. 381–384, 1993. View at: Publisher Site | Google Scholar
  6. M. D. Maines, “The heme oxygenase system: a regulator of second messenger gases,” Annual Review of Pharmacology and Toxicology, vol. 37, pp. 517–554, 1997. View at: Publisher Site | Google Scholar
  7. N. G. Abraham and A. Kappas, “Heme oxygenase and the cardiovascular-renal system,” Free Radical Biology and Medicine, vol. 39, no. 1, pp. 1–25, 2005. View at: Publisher Site | Google Scholar
  8. F. H. Bach, “Heme oxygenase-1: a therapeutic amplification funnel,” The FASEB Journal, vol. 19, no. 10, pp. 1216–1219, 2005. View at: Publisher Site | Google Scholar
  9. N. F. Wiernsperger, “Oxidative stress: the special case of diabetes,” BioFactors, vol. 19, no. 1-2, pp. 11–18, 2003. View at: Google Scholar
  10. V. Bocci, Oxygen-Ozone Therapy: A Critical Evaluation, Kluwer Academic Publishers, Dordrecht, The Netherlands, 2002. View at: Google Scholar
  11. V. Bocci, Ozone: A New Medical Drug, Springer, Dordrecht, The Netherlands, 2005. View at: Google Scholar
  12. V. Bocci, “Scientific and medical aspects of ozone therapy: state of the art,” Archives of Medical Research, vol. 37, no. 4, pp. 425–435, 2006. View at: Publisher Site | Google Scholar
  13. V. Bocci, “Is it true that ozone is always toxic? the end of a dogma,” Toxicology and Applied Pharmacology, vol. 216, no. 3, pp. 493–504, 2006. View at: Publisher Site | Google Scholar
  14. V. Bocci, “The case for oxygen-ozone therapy,” British Journal of Biomedical Science, vol. 64, no. 1, pp. 44–49, 2007. View at: Google Scholar
  15. V. Bocci, “Does ozone therapy normalize the cellular redox balance? implications for the therapy of human immunodeficiency virus infection and several other diseases,” Medical Hypotheses, vol. 46, no. 2, pp. 150–154, 1996. View at: Publisher Site | Google Scholar
  16. E. J. Calabrese, “Paradigm lost, paradigm found: the re-emergence of hormesis as a fundamental dose response model in the toxicological sciences,” Environmental Pollution, vol. 138, no. 3, pp. 379–412, 2005. View at: Publisher Site | Google Scholar
  17. S. M. Keyse and R. M. Tyrrell, “Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite,” Proceedings of the National Academy of Sciences of the United States of America, vol. 86, no. 1, pp. 99–103, 1989. View at: Google Scholar
  18. G. Valacchi and V. Bocci, “Studies on the biological effects of ozone: 11. Release of factors from human endothelial cells,” Mediators of Inflammation, vol. 9, no. 6, pp. 271–276, 2000. View at: Publisher Site | Google Scholar
  19. M. J. Green and H. A. O. Hill, “Chemistry of dioxygen,” Methods in Enzymology, vol. 105, pp. 3–22, 1984. View at: Publisher Site | Google Scholar
  20. M.-L. Hu, “Measurement of protein thiol groups and glutathione in plasma,” Methods in Enzymology, vol. 233, pp. 380–385, 1994. View at: Publisher Site | Google Scholar
  21. J. A. Buege and S. D. Aust, “Microsomal lipid peroxidation,” Methods in Enzymology, vol. 52, pp. 302–310, 1978. View at: Publisher Site | Google Scholar
  22. H. Moshage, B. Kok, J. R. Huizenga, and P. L. Jansen, “Nitrite and nitrate determinations in plasma: a critical evaluation,” Clinical Chemistry, vol. 41, no. 6, pp. 892–896, 1995. View at: Google Scholar
  23. R. Motterlini, R. Foresti, M. Intaglietta, and R. M. Winslow, “NO-mediated activation of heme oxygenase: endogenous cytoprotection against oxidative stress to endothelium,” American Journal of Physiology, vol. 270, no. 1, pp. H107–H114, 1996. View at: Google Scholar
  24. G. L. Peterson, “A simplification of the protein assay method of Lowry et al. which is more generally applicable,” Analytical Biochemistry, vol. 83, no. 2, pp. 346–356, 1977. View at: Publisher Site | Google Scholar
  25. H. J. Duckers, M. Boehm, and A. L. True et al., “Heme oxygenase-1 protects against vascular constriction and proliferation,” Nature Medicine, vol. 7, no. 6, pp. 693–698, 2001. View at: Publisher Site | Google Scholar
  26. K. Sato, J. Balla, and L. Otterbein et al., “Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants,” Journal of Immunology, vol. 166, no. 6, pp. 4185–4194, 2001. View at: Google Scholar
  27. F. H. Bach, “Heme oxygenase-1 as a protective gene,” Wiener Klinische Wochenschrift, vol. 114, supplement 4, pp. 1–3, 2002. View at: Google Scholar
  28. W. Durante, “Heme oxygenase-1 in growth control and its clinical application to vascular disease,” Journal of Cellular Physiology, vol. 195, no. 3, pp. 373–382, 2003. View at: Publisher Site | Google Scholar
  29. M. D. Maines, “The heme oxygenase system: past, present, and future,” Antioxidants and Redox Signaling, vol. 6, no. 5, pp. 797–801, 2004. View at: Publisher Site | Google Scholar
  30. T. Takahashi, K. Morita, R. Akagi, and S. Sassa, “Heme oxygenase-1: a novel therapeutic target in oxidative tissue injuries,” Current Medicinal Chemistry, vol. 11, no. 12, pp. 1545–1561, 2004. View at: Google Scholar
  31. N. O. S. Camara and M. P. Soares, “Heme oxygenase-1 (HO-1), a protective gene that prevents chronic graft dysfunction,” Free Radical Biology and Medicine, vol. 38, no. 4, pp. 426–435, 2005. View at: Publisher Site | Google Scholar
  32. K. Devadas and S. Dhawan, “Hemin activation ameliorates HIV-1 infection via heme oxygenase-1 induction,” Journal of Immunology, vol. 176, no. 7, pp. 4252–4257, 2006. View at: Google Scholar
  33. K. Yamashita, R. Öllinger, and J. McDaid et al., “Heme oxygenase-1 is essential for and promotes tolerance to transplanted organs,” The FASEB Journal, vol. 20, no. 6, pp. 776–778, 2006. View at: Publisher Site | Google Scholar
  34. J. Wang, S. Lu, P. Moënne-Loccoz, and P. R. Ortiz de Montellano, “Interaction of nitric oxide with human heme oxygenase-1,” Journal of Biological Chemistry, vol. 278, no. 4, pp. 2341–2347, 2003. View at: Publisher Site | Google Scholar
  35. C. G. Wong, M. Bonakdar, W. J. Mautz, and M. T. Kleinman, “Chronic inhalation exposure to ozone and nitric acid elevates stress-inducible heat shock protein 70 in the rat lung,” Toxicology, vol. 107, no. 2, pp. 111–119, 1996. View at: Publisher Site | Google Scholar
  36. G. Valacchi, A. van der Vliet, and B. C. Schock et al., “Ozone exposure activates oxidative stress responses in murine skin,” Toxicology, vol. 179, no. 1-2, pp. 163–170, 2002. View at: Publisher Site | Google Scholar
  37. Z. B. Zamora, A. Borrego, and O. Y. López et al., “Effects of ozone oxidative preconditioning on TNF-α release and antioxidant-prooxidant intracellular balance in mice during endotoxic shock,” Mediators of Inflammation, vol. 2005, no. 1, pp. 16–22, 2005. View at: Publisher Site | Google Scholar
  38. H. H. Ajamieh, S. Menéndez, and G. Martínez-Sánchez et al., “Effects of ozone oxidative preconditioning on nitric oxide generation and cellular redox balance in a rat model of hepatic ischaemia-reperfusion,” Liver International, vol. 24, no. 1, pp. 55–62, 2004. View at: Publisher Site | Google Scholar
  39. T.-S. Lee, C.-C. Chang, Y. Zhu, and J. Y.-J. Shyy, “Simvastatin induces heme oxygenase-1: a novel mechanism of vessel protection,” Circulation, vol. 110, no. 10, pp. 1296–1302, 2004. View at: Publisher Site | Google Scholar
  40. N. Grosser, K. Erdmann, and A. Hemmerle et al., “Rosuvastatin upregulates the antioxidant defense protein heme oxygenase-1,” Biochemical and Biophysical Research Communications, vol. 325, no. 3, pp. 871–876, 2004. View at: Publisher Site | Google Scholar
  41. N. Grosser, A. Abate, and S. Oberle et al., “Heme oxygenase-1 induction may explain the antioxidant profile of aspirin,” Biochemical and Biophysical Research Communications, vol. 308, no. 4, pp. 956–960, 2003. View at: Publisher Site | Google Scholar
  42. R. K. Maheshwari, A. K. Singh, J. Gaddipati, and R. C. Srimal, “Multiple biological activities of curcumin: a short review,” Life Sciences, vol. 78, no. 18, pp. 2081–2087, 2006. View at: Publisher Site | Google Scholar

Copyright © 2007 Velio Bocci et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

145 Views | 895 Downloads | 44 Citations
 PDF Download Citation Citation
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.